Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Investigation of Adrenal Incidentalomas in Japanese Patients of the Fukuoka Region with Updated Diagnostic Criteria for Sub-clinical Cushing's Syndrome.
Abe I, Sugimoto K, Miyajima T, Ide T, Minezaki M, Takeshita K, Takahara S, Nakagawa M, Fujimura Y, Kudo T, Miyajima S, Taira H, Ohe K, Ishii T, Yanase T, Kobayashi K. Abe I, et al. Among authors: minezaki m. Intern Med. 2018 Sep 1;57(17):2467-2472. doi: 10.2169/internalmedicine.0550-17. Epub 2018 Apr 27. Intern Med. 2018. PMID: 29709936 Free PMC article.
Clinical investigation of pituitary incidentalomas: A two-center study.
Ishii K, Abe I, Kameda W, Sugimoto K, Morinaga Y, Ito M, Takashi Y, Abe M, Hada Y, Takase K, Fujii H, Ohishi H, Ochi K, Yamao Y, Minezaki M, Kudo T, Higashi T, Sonoda Y, Ishizawa K, Kobayashi K. Ishii K, et al. Among authors: minezaki m. Intractable Rare Dis Res. 2019 Nov;8(4):239-244. doi: 10.5582/irdr.2019.01083. Intractable Rare Dis Res. 2019. PMID: 31890450 Free PMC article.
Investigation of efficacy and safety of low-dose sodium glucose transporter 2 inhibitors and differences between two agents, canagliflozin and ipragliflozin, in patients with type 2 diabetes mellitus.
Sugimoto K, Abe I, Minezaki M, Takashi Y, Ochi K, Fujii H, Ohishi H, Yamao Y, Kudo T, Ohe K, Abe M, Ohnishi Y, Shinagawa T, Mukoubara S, Kobayashi K. Sugimoto K, et al. Among authors: minezaki m. Drug Discov Ther. 2019;13(6):322-327. doi: 10.5582/ddt.2019.01085. Drug Discov Ther. 2019. PMID: 31956230 Free article.
Effect of denosumab, a human monoclonal antibody of receptor activator of nuclear factor kappa-B ligand (RANKL), upon glycemic and metabolic parameters: Effect of denosumab on glycemic parameters.
Abe I, Ochi K, Takashi Y, Yamao Y, Ohishi H, Fujii H, Minezaki M, Sugimoto K, Kudo T, Abe M, Ohnishi Y, Mukoubara S, Kobayashi K. Abe I, et al. Among authors: minezaki m. Medicine (Baltimore). 2019 Nov;98(47):e18067. doi: 10.1097/MD.0000000000018067. Medicine (Baltimore). 2019. PMID: 31764838 Free PMC article.
The Successful Treatment of Myeloperoxidase Antineutrophil Cytoplasmic Antibody-positive Hypertrophic Pachymeningitis in Patients with the Limited Form of Granulomatosis with Polyangiitis Using Methotrexate: Two Case Reports.
Kaieda S, Yoshida N, Minezaki M, Ushijima S, Wakasugi D, Miura S, Uchiyama Y, Ida H, Hoshino T. Kaieda S, et al. Among authors: minezaki m. Intern Med. 2017;56(8):959-965. doi: 10.2169/internalmedicine.56.7742. Epub 2017 Apr 15. Intern Med. 2017. PMID: 28420847 Free PMC article.